Answer
No human fertility trials have been conducted with Glyxambi or its individual active ingredients, empagliflozin and linagliptin; non-clinical studies of each ingredient alone do not indicate direct or indirect harmful effects on fertility.
Sources for this answer
- Glyxambi 10 mg/5 mg film-coated tablets and Glyxambi 25 mg/5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked